BIVALIRUDIN 250 mg/5mL
BIVALIRUDIN · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Meitheal Pharmaceuticals Inc.
No Recall History
Plain English
BIVALIRUDIN is a injection, powder, lyophilized, for solution containing bivalirudin at 250 mg/5mL, taken intravenous. Manufactured by Meitheal Pharmaceuticals Inc..
Key Facts
- Brand Name
- BIVALIRUDIN
- Generic Name
- BIVALIRUDIN
- NDC Code (Product)
71288-427- Manufacturer
- Meitheal Pharmaceuticals Inc.
- Strength
- 250 mg/5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA091602
- Drug Class
- Anti-coagulant [EPC]; Direct Thrombin Inhibitor [EPC]
- Marketing Start
- 07/16/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is BIVALIRUDIN used for?
BIVALIRUDIN contains BIVALIRUDIN. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is BIVALIRUDIN a controlled substance?
BIVALIRUDIN is not classified as a controlled substance by the DEA.
What is the generic name for BIVALIRUDIN?
The generic name for BIVALIRUDIN is BIVALIRUDIN. There are 10 other brand versions of BIVALIRUDIN.
What is the NDC code for BIVALIRUDIN 250 mg/5mL?
The NDC (National Drug Code) for BIVALIRUDIN 250 mg/5mL is 71288-427, listed by Meitheal Pharmaceuticals Inc..